Cargando…
Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer
Breast cancers can metastasize via hematogenous and lymphatic routes, however in some patients only one type of metastases are detected, suggesting a certain proclivity in metastatic patterns. Since epithelial-mesenchymal transition (EMT) plays an important role in cancer dissemination it would be w...
Autores principales: | Markiewicz, Aleksandra, Książkiewicz, Magdalena, Seroczyńska, Barbara, Skokowski, Jarosław, Szade, Jolanta, Wełnicka-Jaśkiewicz, Marzena, Zaczek, Anna J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875950/ https://www.ncbi.nlm.nih.gov/pubmed/24217115 http://dx.doi.org/10.3390/cancers5041485 |
Ejemplares similares
-
Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2018) -
Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
por: Markiewicz, Aleksandra, et al.
Publicado: (2014) -
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2012) -
Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2013) -
Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2019)